Overview
Announcements

Ordinary Rebalance | Solactive China Biotech Innovation Index | Effective Date 15th May 2023

In the ordinary rebalance, the following index composition will be implemented effective open 15.05.2023:

3SBIO INC
ALPHAMAB ONCOLOGY
AMOYTOP BIO ORD A
ANHUI HUAHENG BIOTECHNOLOGY CO LTD
ASCENTAGE PHARMA GROUP INTERNATIONAL
BEIJING BOHUI INNOVATION B-A
BEIJING SL PHARMACEUTICAL -A
BEIJING TIANTAN BIOLOGICAL-A
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO LTD
BGI GENOMICS CO LTD-A
CANSINO BIOLOGICS INC
CHANGCHUN HIGH & NEW TECH-A
CHENGDU KANGHUA BIOLOGICAL PRODUCTS CO LTD
CHENGDU OLYMVAX BIOPHARMACEUTICALS
CHINA ANIMAL HUSBANDRY-A
CHONGQING ZHIFEI BIOLOGICA-A
CSPC PHARMACEUTICAL GROUP LTD
DAAN GENE CO LTD-A
FRONTIER BIOTECHNOLOGIES INC
GENSCRIPT BIOTECH CORP
GETEIN BIOTECH INC-A
GUANGZHOU WONDFO BIOTECH C-A
HEBEI CHANGSHAN BIOCHEMICA-A
HUALAN BIOLOGICAL BACTERIN INC
HUALAN BIOLOGICAL ENGINEER-A
JACOBIO PHARMACEUTICALS GROUP CO LTD
JOINN LABORATORIES CHINA CO LTD
KINTOR PHARMACEUTICAL LTD
LIAONING CHENG DA CO LTD
LIAONING CHENGDA BIOTECHNOLOGY
NANJING VAZYME BIOTECH CO LTD
PACIFIC SHUANGLIN BIO-PHARMACY
SHANGHAI RAAS BLOOD PRODUC-A
SHANGHAI ZJ BIO-TECH CO LT-A
SHENZHEN KANGTAI BIOLOGICA-A
SHENZHEN WEIGUANG BIOLOGIC-A
SICHUAN KELUN PHARMACEUTIC-A
WALVAX BIOTECHNOLOGY CO-A
WUHAN KEQIAN BIOLOGY CO LT-A
WUXI BIOLOGICS CAYMAN INC
ZAI LAB LTD